Department of Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan.
Surg Today. 2019 Jul;49(7):556-570. doi: 10.1007/s00595-019-1763-y. Epub 2019 Jan 11.
The clinical benefits of robotic surgery for patients with rectal cancer have been reported and many systematic reviews have been published. However, they have investigated a variety of outcomes and differ remarkably in quality. In this overview, we summarize the findings of these reviews and evaluate their quality.
The PubMed, Scopus, and Cochrane Central Register of Controlled Trials databases were comprehensively searched to identify systematic reviews and meta-analyses that compared robotic and laparoscopic surgery. We assessed the quality of the reviews using the AMSTAR-2 tool.
The literature search identified 17 eligible reviews, all of which reported that the incidence of conversion to open surgery was lower for robotic surgery than for laparoscopic surgery. Most of the reviews reported no difference in the other outcomes between robotic surgery and laparoscopic surgery. However, the quality of the reviews was judged to be low or critically low.
Critically low quality evidence suggests that robotic surgery for rectal cancer decreases the likelihood of conversion to open surgery, but other clinical benefits remain unclear. High-quality systematic reviews in which selection of high-quality studies is combined with adequate methodology are needed to clarify the true efficacy of robotic surgery for rectal cancer.
已经报道了机器人手术治疗直肠癌患者的临床获益,并且已经发表了许多系统评价。然而,它们调查了各种结果,并且在质量上差异显著。在本次综述中,我们总结了这些评价的结果并评估了其质量。
全面检索 PubMed、Scopus 和 Cochrane 对照试验中心注册数据库,以确定比较机器人手术和腹腔镜手术的系统评价和荟萃分析。我们使用 AMSTAR-2 工具评估了评价的质量。
文献检索确定了 17 项符合条件的评价,所有这些评价都报告机器人手术的中转开腹率低于腹腔镜手术。大多数评价报告机器人手术和腹腔镜手术之间在其他结局上没有差异。然而,评价的质量被判断为低或极低。
极低质量的证据表明,机器人手术治疗直肠癌可降低中转开腹手术的可能性,但其他临床获益尚不清楚。需要高质量的系统评价,其中包括选择高质量的研究并结合适当的方法学,以明确机器人手术治疗直肠癌的真实疗效。